LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 106 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,165 | -54.8% | 268,826 | -2.2% | 0.00% | -100.0% |
| Q2 2023 | $874,188 | +136066.4% | 274,902 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $642 | -29.7% | 272,053 | +3.4% | 0.00% | 0.0% |
| Q4 2022 | $913 | -100.0% | 263,228 | -1.7% | 0.00% | -66.7% |
| Q3 2022 | $1,962,000 | +20.5% | 267,718 | +7.2% | 0.00% | +50.0% |
| Q2 2022 | $1,628,000 | +113.1% | 249,705 | +65.0% | 0.00% | +100.0% |
| Q1 2022 | $764,000 | +324.4% | 151,378 | +549.5% | 0.00% | – |
| Q4 2021 | $180,000 | -28.0% | 23,307 | +38.0% | 0.00% | – |
| Q3 2021 | $250,000 | – | 16,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |